• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Case Reports in Obstetrics and Gynecology >Successful Conservative Treatment of a Cesarean Scar Pregnancy with Systemically Administered Methotrexate and Subsequent Dilatation and Curettage: A Case Report
【24h】

Successful Conservative Treatment of a Cesarean Scar Pregnancy with Systemically Administered Methotrexate and Subsequent Dilatation and Curettage: A Case Report

机译：全身用甲氨蝶呤及随后的扩张和刮除术成功治疗保守性剖宫产瘢痕的病例报告

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Cesarean scar pregnancy is a rare type of ectopic pregnancy associated with severe complications such as uterine rupture, uncontrollable bleeding which may lead to hysterectomy, and definitive infertility. Many therapeutic options are available such as Dilatation & Curetage, excision of trophoblastic tissues using either laparotomy or laparoscopy, systemically administered Methotrexate, and more recently uterine artery embolization. The use of Methotrexate sometimes required laparotomy later because of severe hemorrhage. Through this paper, we demonstrated that viable cesarean scar pregnancy can be managed safely by systemically delivered Methotrexate at the cost of a prolonged followup.
机译：剖宫产疤痕妊娠是一种罕见的异位妊娠，伴有严重的并发症，如子宫破裂，无法控制的出血，可能导致子宫切除术和确定的不孕。可以使用许多治疗选择，例如扩张术和治愈术，使用剖腹术或腹腔镜术切除滋养细胞组织，全身施用甲氨蝶呤以及最近进行的子宫动脉栓塞术。甲氨蝶呤的使用有时会因严重出血而在以后进行剖腹手术。通过本文，我们证明了可以通过系统地分娩甲氨蝶呤安全地管理可行的剖宫产疤痕妊娠，但需要延长随访时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号